Loading interface...

BRINZOMA EYE DROPS

Manufactured bySunways (India) Pvt. Ltd.
ContainsBrinzolamide
Description

BRINZOMA EYE DROPS is a topical carbonic anhydrase inhibitor used in the treatment of increased fluid pressure inside the eyes (intraocular hypertension) and open-angle glaucoma, a progressive condition that may eventually lead to vision loss. This medicine is not recommended for use in patients below 18 years of age.

Side effects

Major & minor side effects for BRINZOMA EYE DROPS

  • Blurred vision
  • Dry eyes
  • Skin Rash
  • Redness, soreness, irritation or pain of the eye lid
  • Discharge from eyes
  • Dizziness
  • Double vision

Uses of BRINZOMA EYE DROPS

What is it prescribed for?

  • Intraocular hypertension
  • Open angle Glaucoma
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed within 1 hour of administration of the dose.
  • How long do the effects of this medicine last?
    The effect of this medicine lasts for an average duration of 4 to 8 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to brinzolamide or any other inactive ingredients present along with this medicine.

Severe renal impairment

This medicine is not recommended for use in patients with severe renal impairment (creatinine clearance less than 30 ml/min) since the safety and efficacy of use are not clinically established for such patients.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before using this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.
General warnings

Liver impairment

This medicine should be used with caution in patients with known history of liver diseases due to the increased risk of severe side effects. Report any unusual symptoms to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.

Corneal edema

This medicine should be used with caution since it increases the risk of corneal edema. This risk is especially high in patients with a low number of endothelial cells. Report any eye swelling to the doctor immediately. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Driving or Operating machines

This medicine may cause blurred vision or dizziness in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Use in pediatrics

This medicine is not recommended for use in patients below 18 years of age since the safety and efficacy of use are not clinically established.

Contact lens

This medicine is not recommended for use if you are wearing soft contact lenses in your eyes. The lens should be removed prior to administration of the eye drops and can be reinserted 15 minutes post administration.

Missed Dose

Administer the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Oral carbonic anhydrase inhibitors

Bismuth subsalicylate

Disease interactions

Hematologic toxicity

This medicine should be used with caution in patients with a previous history of blood cell disorders or bone marrow suppression due to the increased risk of worsening of the patient's condition. This risk is especially high if the medicine is used for a prolonged period of time. Close monitoring of complete blood counts is necessary for such patients. Report any symptoms such as a fever, sore throat, bleeding, pallor, or dizziness to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be necessary in some cases based on the clinical condition.

Porphyria

This medicine should be used with extreme caution in patients suffering from porphyria due to the increased risk of an acute attack of porphyria. These patients should be monitored closely for any unusual symptoms. Emergency medical treatment may be needed if any symptoms such as severe abdominal pain, muscle pain, extreme weakness, anxiety, red or brown urine, etc. appear. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary in such cases based on the clinical condition.

Renal Diseases

This medicine should be used with caution in patients with a history of renal diseases due to the increased risk of severe adverse effects. Report any unusual symptoms to the doctor immediately. Close monitoring of kidney function, appropriate dose adjustments, or replacement with a suitable alternative may be necessary in some cases based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
Use this medicine exactly as prescribed. Do not administer in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works
This medicine works by reducing the fluid pressure inside the eyes.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Ophthalmic glaucoma agents

Schedule

Schedule H

Brinzolamide - DrugBank [Internet]. Drugbank.ca. 2018 [cited 21 March 2018]. Available from:

https://www.drugbank.ca/drugs/DB01194

DailyMed - brinzolamide suspension/ drops [Internet]. Dailymed.nlm.nih.gov. 2018 [cited 21 March 2018]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e9ea2ae7-1b98-4034-9fba-8ce2225e0145

Brinzolamide Ophthalmic: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2018 [cited 21 March 2018]. Available from:

https://medlineplus.gov/druginfo/meds/a601233.html

[Internet]. 2018 [cited 21 March 2018]. Available from:

https://www2.medicines.org.uk/emc/medicine/33734

[Internet]. 2018 [cited 21 March 2018]. Available from:

https://www2.medicines.org.uk/emc/PIL.16330.latest.pdf

Prescribing medicines in pregnancy database [Internet]. Therapeutic Goods Administration (TGA). 2018 [cited 21 March 2018]. Available from:

http://www.tga.gov.au/prescribing-medicines-pregnancy-database

[Internet]. Accessdata.fda.gov. 2018 [cited 21 March 2018]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020816s019lbl.pdf

[Internet]. Medsafe.govt.nz. 2018 [cited 21 March 2018]. Available from:

http://www.medsafe.govt.nz/profs/Datasheet/a/Azopteyedrop.pdf
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 30 Mar 2018

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.